Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
03 03 2020
Historique:
pubmed: 24 9 2019
medline: 22 6 2021
entrez: 24 9 2019
Statut: ppublish

Résumé

The main objective of this

Identifiants

pubmed: 31545130
doi: 10.1080/21645515.2019.1669413
pmc: PMC7227663
doi:

Substances chimiques

Antibodies, Viral 0
Papillomavirus Vaccines 0
Vaccines, Combined 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

590-594

Références

Vaccine. 2016 Jul 29;34(35):4205-4212
pubmed: 27354258
Euro Surveill. 2018 Oct;23(41):
pubmed: 30326995
J Obstet Gynaecol Res. 2018 Jun;44(6):989-997
pubmed: 29517117
Hum Vaccin Immunother. 2019;15(7-8):1962-1969
pubmed: 30633598
Lancet Infect Dis. 2017 Dec;17(12):1293-1302
pubmed: 28965955
Hum Vaccin Immunother. 2014;10(12):3435-45
pubmed: 25483701
J Infect Dis. 2018 Jan 4;217(2):213-222
pubmed: 29140439
Hum Vaccin Immunother. 2014;10(5):1147-54
pubmed: 24553190
Hum Vaccin. 2007 Jul-Aug;3(4):109-15
pubmed: 17611417
Vaccine. 2015 Nov 27;33(48):6855-64
pubmed: 26411885
J Immunol Methods. 2015 Feb;417:107-114
pubmed: 25554636
J Infect Dis. 2019 Jan 9;219(3):382-390
pubmed: 30299519
Vaccine. 2014 Sep 15;32(41):5357-62
pubmed: 25045814
Epidemiol Infect. 2016 Feb;144(3):449-68
pubmed: 26429676
Gynecol Oncol. 2013 Sep;130(3):642-51
pubmed: 23747835
MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30
pubmed: 25167164
Sex Transm Dis. 2018 Apr;45(4):260-265
pubmed: 29465705
Vaccine. 2017 Jul 13;35(32):3922-3929
pubmed: 28633892
Vaccine. 2018 May 31;36(23):3221-3230
pubmed: 29724506
Lancet Infect Dis. 2015 May;15(5):565-80
pubmed: 25744474
Hum Vaccin Immunother. 2013 Jul;9(7):1399-406
pubmed: 23571174
Infect Agent Cancer. 2014 Sep 01;9:29
pubmed: 25206925
Vaccine. 2018 Nov 12;36(46):7017-7024
pubmed: 30314913
Hum Vaccin Immunother. 2019;15(2):503-507
pubmed: 30252583
PLoS One. 2018 Aug 3;13(8):e0201653
pubmed: 30075010

Auteurs

Chantal Sauvageau (C)

Division of Biological Risks, Quebec Public Health Institute, Quebec, Quebec, Canada.
Division of Infectious Disease and Immunity, Laval University Research Hospital Center, Quebec, Quebec, Canada.

Gitika Panicker (G)

Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Georgia, Atlanta, USA.

Elizabeth R Unger (ER)

Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Georgia, Atlanta, USA.

Gaston De Serres (G)

Division of Biological Risks, Quebec Public Health Institute, Quebec, Quebec, Canada.
Division of Infectious Disease and Immunity, Laval University Research Hospital Center, Quebec, Quebec, Canada.

John Schiller (J)

Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD, USA.

Manale Ouakki (M)

Division of Biological Risks, Quebec Public Health Institute, Quebec, Quebec, Canada.

Vladimir Gilca (V)

Division of Biological Risks, Quebec Public Health Institute, Quebec, Quebec, Canada.
Division of Infectious Disease and Immunity, Laval University Research Hospital Center, Quebec, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH